Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Succimer (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Tiopronin |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Deferoxamine (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Trientine (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Product containing dimercaprol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Product containing heavy metal antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
1 |
dimercaprol 50 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Penicillamine [metabolic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Penicillamine [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Penicillamine 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Penicillamine 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Penicillamine 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
natriumfluorid 1,2 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
natriumfluorid 2,0 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Penicillamine 125 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
edetatdinatrium 150 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
natriumfluorid 1,23 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Product containing precisely penicillamine 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
natriumfluorid 1,1 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Product containing penicillamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Poisoning by heavy metal antagonist |
Causative agent |
True |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
1 |
natriumcalciumedetat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Pentetate calcium trisodium (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Pentetate zinc trisodium (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Dimercaprol (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Penicillamine (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Sodium calcium edetate |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Deferasirox (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Pentetic acid (substance) |
Is a |
False |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
|
Administration of heavy metal antagonist |
Direct substance |
True |
Heavy metal antagonist (substance) |
Inferred relationship |
Some |
1 |